Utrecht
Netherlands
76
2025-12-04
The entities that hold a legal rights for patent applications filed by inventor THROSBY Mark:
Mark THROSBY from Utrecht, NL has applied for patents for these inventions. The list has both pending applications and granted patents:
BISPECIFIC ANTIBODY
#2 | 2025-08-28TGF-BETA-RII BINDING PROTEINS
#3 | 2025-07-17GENERATION OF BINDING MOLECULES
#4 | 2024-10-17BINDING MOLECULES THAT INHIBIT CANCER GROWTH
#5 | 2024-08-29BISPECIFIC ANTIBODY
#6 | 2024-06-27BINDING MOLECULES THAT BIND CD137 AND PD-L1
#7 | 2024-06-20ERBB-2 AND ERBB3 BINDING BISPECIFIC ANTIBODIES FOR USE IN THE TREATMENT OF CELLS THAT HAVE AN NRG1 FUSION GENE
#8 | 2024-06-06ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene
#9 | 2024-05-30ANTIBODIES THAT BIND EGFR AND CMET
#10 | 2024-05-16ANTIBODY THAT BINDS ERBB-2 AND ERBB-3
#11 | 2024-05-16ANTIBODY THAT BINDS ERBB-2 AND ERBB-3
#12 | 2024-05-16ANTIBODY PRODUCING NON-HUMAN ANIMALS
#13 | 2024-02-15ANTIBODIES THAT BIND EGFR AND ERBB3
#14 | 2024-02-01BINDING MOLECULES THAT MODULATE A BIOLOGICAL ACTIVITY EXPRESSED BY A CELL
#15 | 2024-01-25ANTIBODY PRODUCING NON-HUMAN ANIMALS
#16 | 2023-12-21ANTIBODIES THAT MODULATE A BIOLOGICAL ACTIVITY EXPRESSED BY A CELL
#17 | 2023-11-09BISPECIFIC ANTI PD1-ANTI TIM3 ANTIBODIES
#18 | 2023-08-03Antibody that binds ErbB-2 and ErbB-3
#19 | 2023-07-06MEANS AND METHOD FOR MODULATING IMMUNE CELL ENGAGING EFFECTS
#20 | 2023-05-25Generation of binding molecules
#21 | 2023-03-16TREATMENT OF CANCER WITH A COMBINATION OF AN ANTIBODY THAT BINDS LGR5 AND EGFR AND A TOPOISOMERASE I INHIBITOR
#22 | 2022-11-03ANTIBODY THAT BINDS ERBB-2 AND ERBB-3
#23 | 2022-09-08BISPECIFIC ANTIBODY
#24 | 2022-06-16BISPECIFIC ANTIBODY
#25 | 2022-04-28COMBINATIONS OF BINDING MOIETIES THAT BIND EGFR, HER2 AND HER3
#26 | 2021-10-28Bispecific antibody
#27 | 2021-07-15Bispecific antibody
#28 | 2021-07-08ERBB-2 TARGETING AGENT AND A BISPECIFIC ANTIBODY WITH ANTIGEN-BINDING SITES THAT BIND AN EPITOPE ON AN EXTRACELLULAR PART OF ERB-2 AND ERBB-3, FOR TREATMENT OF AN INDIVIDUAL WITH AN ERBB-2, ERBB-2/ERBB-3 POSITIVE TUMOUR
#29 | 2021-05-27Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumor
#30 | 2020-10-15Binding molecules that modulate a biological activity expressed by a cell
#31 | 2020-10-08ANTIBODY PRODUCING NON-HUMAN ANIMALS
#32 | 2020-09-17ANTIBODIES FOR THE TREATMENT OF ERBB-2/ERBB-3 POSITIVE TUMORS
#33 | 2020-08-06Generation of binding molecules
#34 | 2020-08-06Antibodies that bind EGFR and cMET
#35 | 2020-07-09Antibodies that modulate a biological activity expressed by a cell
#36 | 2020-07-09Bispecific anti PD1-anti TIM3 antibodies
#37 | 2020-04-02ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene
#38 | 2020-01-16Binding molecules that bind CD137 and PD-L1
#39 | 2018-11-01Binding molecules that inhibit cancer growth
#40 | 2018-06-28Generation of binding molecules
#41 | 2018-05-24ANTIBODY PRODUCING NON-HUMAN ANIMALS
#42 | 2018-05-24ANTIBODY PRODUCING NON-HUMAN ANIMALS
#43 | 2018-05-24ANTIBODY PRODUCING NON-HUMAN ANIMALS
#44 | 2018-05-24Antibody producing non-human animals
#45 | 2018-05-17Antibody producing non-human animals
#46 | 2018-02-01Antibody producing non-human animals
#47 | 2017-03-02Antibodies that bind EGFR and ErbB3
#48 | 2017-02-09Antibody that binds ErbB-2 and ErbB-3
#49 | 2016-08-18Antibody producing non-human animals
#50 | 2016-05-12Generation of binding molecules
#51 | 2016-01-28Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
#52 | 2015-06-25HUMAN BINDING MOLECULES CAPABLE OF NEUTRALIZING INFLUENZA VIRUS H3N2 AND USES THEREOF
#53 | 2014-10-23Antibody producing non-human mammals
#54 | 2014-10-23Antibody producing non-human mammals
#55 | 2014-04-10Human binding molecules having killing activity against enterococci
#56 | 2014-03-06Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
#57 | 2013-11-21Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof
#58 | 2013-04-18Generation of binding molecules
#59 | 2012-12-13Human binding molecules against and
#60 | 2012-11-01Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
#61 | 2012-06-07Human binding molecules having killing activity against staphylococci and uses thereof
#62 | 2012-04-19Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
#63 | 2012-03-29Host cell specific binding molecules capable of neutralizing viruses and uses thereof
#64 | 2012-02-16Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof
#65 | 2011-11-03Human binding molecules having killing activity against enterococci and uses thereof
#66 | 2010-12-02Host cell specific binding molecules capable of neutralizing viruses and uses thereof
#67 | 2010-06-10Antibody producing non-human mammals
#68 | 2010-03-18Antibody producing non-human mammals
#69 | 2009-12-17Human bind molecules capable of neutralizing influenza virus h5n1 and uses thereof
#70 | 2009-07-02Human binding molecules having killing activity against enterococci and uses thereof
#71 | 2009-05-21Optimization of West Nile Virus Antibodies
#72 | 2009-04-23Human binding molecules having killing activity against staphylococci and uses thereof
#73 | 2009-02-26Method for preparing immunoglobulin libraries
#74 | 2007-05-31Binding molecules capable of neutralizing West Nile virus and uses thereof
#75 | 2007-02-22Binding molecules capable of neutralizing west nile virus and uses thereof
#76 | 2006-11-16Human binding molecule against CD1a
198614 ⎘